Reaction Details |
| Report a problem with these data |
Target | Mitogen-activated protein kinase 14 |
---|
Ligand | BDBM50206423 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_462165 (CHEMBL944993) |
---|
IC50 | 2200±n/a nM |
---|
Citation | Peifer, C; Urich, R; Schattel, V; Abadleh, M; Röttig, M; Kohlbacher, O; Laufer, S Implications for selectivity of 3,4-diarylquinolinones as p38alphaMAP kinase inhibitors. Bioorg Med Chem Lett18:1431-5 (2008) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Mitogen-activated protein kinase 14 |
---|
Name: | Mitogen-activated protein kinase 14 |
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta |
Type: | Serine/threonine-protein kinase |
Mol. Mass.: | 41286.76 |
Organism: | Homo sapiens (Human) |
Description: | Q16539 |
Residue: | 360 |
Sequence: | MSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ
SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ
KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG
TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA
QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLTYDEVISFVPPPLDQEEMES
|
|
|
BDBM50206423 |
---|
n/a |
---|
Name | BDBM50206423 |
Synonyms: | 4-(5-(4-fluorophenyl)-3-isopropylisoxazol-4-yl)pyridine | 4-[5-(4-fluorophenyl)-3-isopropylisoxazol-4-yl]pyridine | 5-(4-fluorophenyl)-3-isopropyl-4-(pyridin-4-yl)isoxazole | CHEMBL375428 |
Type | Small organic molecule |
Emp. Form. | C17H15FN2O |
Mol. Mass. | 282.3122 |
SMILES | CC(C)c1noc(c1-c1ccncc1)-c1ccc(F)cc1 |
Structure |
|